MULTI-TARGETING SHORT INTERFERING RNAs
AssigneeCity of Hope
InventorsJohn J. ROSSI, Ola SNOVE, JR., Ali EHSANI, Pal SAETROM, JR., Britta HOEHN, Jane ZHANG, Lars AAGAARD
Life of this patent
Estimating the term…
Loading patent…
AssigneeCity of Hope
InventorsJohn J. ROSSI, Ola SNOVE, JR., Ali EHSANI, Pal SAETROM, JR., Britta HOEHN, Jane ZHANG, Lars AAGAARD
Estimating the term…
The present invention relates to novel short interfering RNA (siRNA) molecules that are multi-targeted. More specifically, the present invention relates to siRNA molecules that target two or more sequences. In one embodiment, multi-targeting siRNA molecules are designed to incorporate features of siRNA molecules and features of micro-RNA (miRNA) molecules. In another embodiment, multi-targeting siRNA molecules are designed so that each strand is directed to separate targets.
A method of treating a disease or condition which comprises administering a therapeutically effective amount of a multi-targeting RNA molecule to an individual in need thereof, wherein the multi-targeting RNA molecule targets two or more different desired target sequences, wherein the RNA molecule comprises a first strand having a 5′ terminus and a 3′ terminus and a second strand having a 5′ terminus and a 3′ terminus, wherein the first strand is perfectly complementary to a desired mRNA target sequence, wherein the second strand contains two or more seed matches optimally spaced in a desired 3′ UTR containing target gene, wherein the first strand and second strand are not completely complementary and wherein the first strand and the second strand hybridize to form a double stranded RNA molecule, wherein the double stranded RNA molecule is a single duplex.
A method for designing a multi-targeting RNA molecule comprising:
A multi-targeting RNA molecule that targets two different desired mRNA target sequences, wherein the siRNA comprises a first strand having a 5′ terminus and a 3′ terminus and a second strand having a 5′ terminus and a 3′ terminus, wherein the first strand is 19-30 nucleotides in length, wherein the second strand is 19-30 nucleotides in length, wherein the first strand is perfectly complementary to a first desired mRNA target sequence, wherein the second strand is perfectly complementary to a second and different desired mRNA target sequence, wherein the first strand and second strand are not completely complementary and wherein the first strand and the second strand hybridize to form a double stranded siRNA, wherein the double stranded siRNA is a single duplex.
Dependencies are inferred from the claim text.